Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06455371

Patient-centered Dosage of Levothyroxine

Led by University Hospital of North Norway · Updated on 2025-09-10

240

Participants Needed

3

Research Sites

153 weeks

Total Duration

On this page

Sponsors

U

University Hospital of North Norway

Lead Sponsor

S

SINTEF Health Research

Collaborating Sponsor

AI-Summary

What this Trial Is About

Levothyroxine is the most used thyroid hormone replacement when the thyroid gland is failing. Because dosage adjustment normally takes several months, the investigators have developed a decision support tool (DST) that predicts optimal dosage based on repeated blood samples the first 2 weeks after initiation of therapy. In this randomized study the investigators will include patients that start levothyroxine therapy after total thyroidectomy. The use of DST to advice the physician about an early dosage adjustment will be compared with common clinical practice, that is dosage adjustment every 2 months. The effect of DST use will be assessed by studying the possible relationship between fast optimal dose adjustment, patient reported outcome measures, and ability to work.

CONDITIONS

Official Title

Patient-centered Dosage of Levothyroxine

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Total or completion thyroidectomy for differentiated thyroid cancer or benign thyroid nodules at Norwegian hospitals
Not Eligible

You will not qualify if you...

  • Anaplastic thyroid cancer
  • Thyroid cancer with distant metastasis
  • Graves disease
  • Toxic nodules
  • Pregnancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Haukeland University Hospital

Bergen, Norway

Actively Recruiting

2

Oslo University Hospital

Oslo, Norway

Actively Recruiting

3

University Hospital of North Norway

Tromsø, Norway, 9010

Actively Recruiting

Loading map...

Research Team

V

Vegard Brun, PhD

CONTACT

S

Solveig Brun, cand.med

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Patient-centered Dosage of Levothyroxine | DecenTrialz